GlassScriptPhysician profile
Janet Matuszek
NPI 1265542146
$7,500.01
in general payments reported to CMS, 2019-2025
45 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,236 · 2020: $1,169 · 2021: $1,767 · 2022: $1,545 · 2023: $1,012 · 2024: $432 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,783.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $1,828.50 | 2019-2023 | Balcoltra |
| Abbvie INC. | $1,406.24 | 2019-2025 | |
| Evofem Biosciences, INC. | $360.65 | 2020-2025 | Phexxi, Solosec, Phexx |
| Novo Nordisk INC | $353.88 | 2021-2025 | Wegovy |
| Pfizer INC. | $302.93 | 2019-2025 | |
| Therapeuticsmd, INC. | $224.35 | 2019-2022 | |
| Lupin INC. | $222.55 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $221.47 | 2021-2023 | |
| Mission Pharmacal Company | $220.51 | 2019-2021 | |
| Exeltis, USA INC. | $190.40 | 2020-2025 | Slynd |
| Myovant Sciences INC. | $180.44 | 2021-2022 | |
| Allergan, INC. | $156.97 | 2019-2021 | |
| Aspira Women'S Health INC | $147.00 | 2021-2022 | |
| Hologic Sales and Service, LLC | $120.09 | 2020-2024 | Third Wave, Aptima, Thinprep 2000 Processor |
| Idorsia Pharmaceuticals US INC | $93.29 | 2022-2023 | Quviviq |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Matuszek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.